How to Proactively Manage GLP-1 Discontinuation

Starting a GLP-1 is structured. Stopping them often isn’t. Patients stop taking GLP-1s for different reasons, and they're often surprised by how quickly their effects wear off. Proactively addressing physiologic changes and taper plans can improve outcomes. So don’t wait until patients stop taking GLP-1s to talk about stopping GLP-1s. 

Symptom return is biological, not behavioral

Part of counseling patients in stopping a GLP-1 includes setting expectations. Appetite, cravings, and food noise will likely return, and it’s helpful for patients to know this is a physiologic change, not a behavioral one. It’s not a personal failing to experience hunger. Hunger just needs to be managed with a plan.

Setting these expectations can help patients navigate the mental and emotional aspect of stopping their medication. A patient might think they lost willpower when they stopped their GLP-1. But what they actually lost was pharmacology. 

Stopping GLP-1s should be a transition, not a cliff

When a patient starts a GLP-1, there is a structured titration plan. Stopping a GLP-1 should also follow a plan. Patients may have an easier time maintaining the routines they’ve built while taking a GLP-1 if they slowly taper down on the medication. An abrupt discontinuation can be too disruptive and make it harder to manage the return of appetite and cravings.

Clinicians can help during this transition by providing a titration plan and structure. Recommending alternative weight-loss medications (if appropriate) may also be a good way to bridge this transition period. Be sure to check in often during the discontinuation and reiterate that stopping a GLP-1 doesn’t mean stopping the care plan.

Plan for what comes next

Patients can often discontinue medications for other conditions while taking a GLP-1. Having a structured follow-up plan in place before discontinuation can help mitigate patient risk. During followup appointment, be sure to monitor for changes in glycemic control, cholesterol levels, and blood pressure, among other factors, to address any issues that arise. 

In this period, it’s important to frame reinitiation of a GLP-1 as an option in their care plan and not a sign of failure.